Cash Flow - Lyell Immunopharma, Inc. (LYEL)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -150.02 | -162.39 | -163.69 | -169.56 | -126.25 | -160.87 | 39.47 |
| Cash flow from investing | 54.10 | 122.42 | 184.05 | -11.54 | -121.57 | -273.52 | -422.43 |
| Cash flow from financing | 50.41 | 1.33 | 1.74 | 10.64 | 401.24 | 476.79 | 351.16 |
| Change in cash | -45.52 | -38.64 | 22.10 | -170.46 | 153.42 | 42.40 | -31.80 |
Show Quarterly Cash Flow
Cash Flow - Lyell Immunopharma, Inc. (LYEL)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -38.51 | -32.25 | -28.58 | -34.46 | -54.74 | -47.24 | -35.04 | -38.09 | -42.02 | -40.64 | -37.69 | -39.16 | -46.21 | -40.27 | -37.10 | -44.33 | -47.85 | -33.17 | -25.49 | -33.95 | -33.60 | -26.73 | -21.63 | -88.92 | -23.59 |
| Cash flow from investing | 17.38 | -31.37 | 3.35 | 12.65 | 69.47 | 53.51 | 1.92 | 45.01 | 21.99 | -100.69 | 99.67 | 152.91 | 32.15 | 46.65 | -57.09 | 25.02 | -26.12 | -73.90 | -144.91 | -39.47 | 136.68 | 32.39 | -89.95 | -99.88 | -116.08 |
| Cash flow from financing | 51.72 | 0.22 | 50.00 | 0.18 | 0.00 | 0.44 | 0.00 | 0.86 | 0.03 | 0.76 | -0.14 | 1.20 | -0.07 | 0.86 | 4.76 | 2.46 | 2.56 | 7.40 | -0.53 | 393.49 | 0.88 | 0.34 | 0.04 | 0.00 | 476.42 |
| Change in cash | 30.59 | -63.39 | 24.77 | -21.63 | 14.73 | 6.70 | -33.12 | 7.78 | -20.00 | -140.57 | 61.84 | 114.95 | -14.13 | 7.24 | -89.43 | -16.86 | -71.42 | -99.68 | -170.94 | 320.07 | 103.96 | 5.99 | -111.54 | -188.80 | 336.75 |